FDA NDC Directory · JSON-LD · Markdown

REZLIDHIA

NDC 71332-005 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameolutasidenib
Labeler / ManufacturerRigel Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA215814
Dosage form / routeCAPSULE · ORAL
Active ingredientsOLUTASIDENIB (150 mg/1)
Marketing started20221201
Package count1

External sources

Source: openFDA. Public-domain (CC0).